UCI Health clinician Alpesh Amin launches clinical trial to test remdesivir

UC-Irvine Health clinicians Dr. Alpesh N. Amin and Lanny Hsieh have launched a clinical trial to test the efficacy of the antiviral drug remdesivir as a potential therapy for COVID-19, the disease caused by the novel coronavirus that has reached pandemic levels across the globe. … “There is currently no safe, effective treatment for COVID-19,” Amin, chair of the Department of Medicine, UCI School of Medicine and executive director, UCI Health Hospitalist Program, said in a UCI press release. “While remdesivir has shown some promise, we need solid clinical data that indicates it improves outcomes for infected patients,” the Indian American researcher added.